Tuesday, July 26, 2016 12:34:09 AM
CTIX has yet to fail on any major trials or milestones, yet the stock is off 80% from its highs. Again this is volatility, not risk. I feel there is a high probability one of the compounds proceeds to the point where the stock price will better reflect the true opportunity and company value.
My comments above are based on a conversation I had yesterday with a friend who manages a 100M hedge fund (mostly his own money) and we were talking about the hubris of the markets and how it's hard to know what to do given today's environment. He mentioned that several of his big bets are way underwater but he doesn't consider those high risk plays but they are highly volatile as 50%-70% price moves are common. He is totally confident about where the prices will move, he's just not sure on the timing. As a money manager that is hard as most investors don't have the stomachs to watch and hold paper losses.
I think this line of thought is very relevant to CTIX - it is a very volatile issue in a volatile space but that doesn't necessarily mean it's a "risky" play.
I think when I first bought in 2012 and 2013 CTIX was a high risk play because there was a moderate to high probability of me losing my total investment. Given the progress of the past four years, I no longer see that as a significant risk. What I'm faced with now is trying to keep my fingers off the buy button as I already have significantly more CTIX stock than my allocations call for but the price and value are so compelling.
CTIX is doing very well on most measurements just not on stock price appreciation. That said I feel Leo is very serious about building value and seems to be learning from his past mistakes. I'm very positive on CTIX and continue to accumulate and hold.
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM